Mon.Feb 27, 2023

article thumbnail

Rates of Sadness, Violence Increased in Teenage Girls

Drug Topics

A recent CDC report detailed the increased rates of sadness and violence among teenage girls.

468
468
article thumbnail

As clinical trials face a hiring crunch, here’s how research organizations can pivot

PharmaVoice

Staffing shortages are causing inefficiencies in clinical trials, but one leading CRO is finding ways to adapt.

264
264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cardinal Health Releases 2023 Biosimilars Report

Drug Topics

The new report reviewed the potential impact of biosimilars across multiple specialties.

247
247
article thumbnail

Who is Vivek Ramaswamy — the biotech entrepreneur turned presidential candidate?

PharmaVoice

The former CEO of Roivant, who became the face of the “anti-woke” business movement, is now running for the 2024 Republican presidential nomination. Here’s what he stands for.

246
246
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

DEA's proposed telehealth rules pull back COVID-era remote prescribing flexibilities

Fierce Healthcare

DEA's proposed telehealth rules pull back COVID-era remote prescribing flexibilities aburky Mon, 02/27/2023 - 14:17

131
131
article thumbnail

One type of artificial sweetener may increase heart attack risk, preliminary study says

STAT

The sweetener erythritol, which is becoming increasingly popular in snack bars and low-sugar ice cream substitutes, may increase the risk of heart attacks and strokes, according to a paper published Monday in the journal Nature Medicine. Outside experts who reviewed the findings emphasized that more evidence is needed, with some raising concerns that the results of the study could be due to other factors that make it appear the sweetener causes risks when it does not.

100
100

More Trending

article thumbnail

2023: A Promising Year for ISPE’s Women in Pharma®

ISPE

2023: A Promising Year for ISPE’s Women in Pharma® Trudy Patterson Mon, 02/27/2023 - 11:49 iSpeak Blog iSpeak 2023: A Promising Year for ISPE’s Women in Pharma® Edyna Miguez 27 February 2023 Just off the heels of ISPE’s Facilities of the Future Conference, which took place this past February, ISPE’s Women in Pharma continues to leverage its momentum to amplify the group’s mission to create a more equitable pharmaceutical industry on a grand scale.

98
article thumbnail

Mayo Clinic income dips in 2022 after facing higher labor and supply expenses

Fierce Healthcare

Mayo Clinic income dips in 2022 after facing higher labor and supply expenses rking Mon, 02/27/2023 - 15:19

article thumbnail

Meet the contenders for STAT Madness 2023. Voting begins March 1

STAT

Entries for this year’s STAT Madness, our annual, bracket-style competition in biomedical research, include some of 2022’s biggest discoveries, in areas ranging from Covid-19 and cancer treatment to medical imaging and surgery. Popular voting begins on Wednesday, March 1, when first-round pairings will be revealed, along with descriptions of all the entrants’ research.

98
article thumbnail

UPMC, DOJ settle whistleblower suit alleging 'world-renowned' surgeon performed, billed simultaneous surgeries

Fierce Healthcare

UPMC, DOJ settle whistleblower suit alleging 'world-renowned' surgeon performed, billed simultaneous surgeries dmuoio Mon, 02/27/2023 - 14:14

111
111
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: How Eric Lander’s sharp elbows spurred MIT’s Nancy Hopkins to start a gender revolution

STAT

It looked like the perfect collaboration. The Massachusetts Institute of Technology was preparing to roll out a new introductory course in biology, the first time the subject would be required for all undergraduates. It was 1991, and the university turned to two scientists who already were standouts.

98
article thumbnail

Helping the Whole Person | Avita Pharmacy

PioneerRx

The effectiveness of patient care has changed and evolved over the years. For all the new advances in technology and modern medicine, the quality of care is only.

article thumbnail

Opinion: Nonprofit hospitals are failing Americans. Their boards may be a reason why

STAT

More than half of U.S. hospitals are nonprofit, meaning they receive generous tax exemptions in exchange for benefiting their communities. Many aren’t fulfilling that mission. Some nonprofits have billed patients who should have qualified for charity care, racking up billions of dollars in charges. Some have aggressively collected on medical debt through legal action or reports to credit agencies.

article thumbnail

Health Park Pharmacy | Trailblazing COVID-19 Treatment

PioneerRx

Tucked away in the heart of Raleigh, NC, one independent pharmacy is serving its community and setting an example for others to follow. Since the start of the.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: FDA’s Billy Dunn, key figure in approval of Aduhelm, to leave agency

STAT

Billy Dunn, who presided over the polarizing approval of the Alzheimer’s disease treatment Aduhelm, is leaving the Food and Drug Administration after more than 15 years at the agency , STAT has learned. Dunn, 53, is retiring from the agency to “explore other opportunities,” according to an internal FDA email sent Monday. Dunn notified agency officials Friday, according to a person with knowledge of the situation.

FDA 98
article thumbnail

Celebrating You, Today and Every Day

PioneerRx

Cue the confetti: Wednesday, January 12th is a special day — and it’s all about you. Every year, National Pharmacist Day recognizes the innovations, improvements.

98
article thumbnail

Lipid lowering therapy benefits ethnic patients despite under-representation in trials

Hospital Pharmacy Europe

A systematic review suggests that ethnic and regional patients are often under-represented in lipid lowering trials yet still derive benefits Despite being under-represented in randomised controlled trials of lipid lowering therapy, a systemic review has found that ethnic patients and those from different geographical regions still benefit from these treatments according to a systematic review by UK and Australian researchers The benefits of LDL cholesterol-lowering treatment as a preventative s

article thumbnail

The Road to the Third Dose | Tarrytown Pharmacy

PioneerRx

In the hustle and bustle of one of the nation’s fastest-growing cities, Tarrytown Pharmacy is a source of constancy. Since 1941, Tarrytown has been serving the.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

How to lose weight with insulin resistance

The Checkup by Singlecare

If you are insulin resistant, losing weight may be harder for you than the average person. Why? A body needs insulin—a hormone produced by your pancreas—to move sugar from the bloodstream into the cells to be used for energy. Insulin resistance causes cells to become less responsive to insulin. Insulin resistance is very common: It is the hallmark of prediabetes and Type 2 diabetes.

article thumbnail

PioneerRx Addresses Drug Safety Compliance With Multi-Batch Compounding

PioneerRx

Irving, TX - PioneerRx Pharmacy Software has released a new Multi-Batch Compounding feature to help increase safety and accuracy for pharmacies in providing.

article thumbnail

STAT+: Pharmalittle: Pfizer in talks to acquire Seagen; U.S. trade rep urged not to sanction countries that sidestep Vertex patents

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. To cope, we are firing up the coffee kettle and brewing cups of stimulation. Our choice today is roasted coconut, for those tracking this sort of thing.

98
article thumbnail

Just Say the Magic Word | Pharmacy History

PioneerRx

If you’re a pharmacy enthusiast looking to learn more, join us on this blast to the past to uncover some of the most important moments in the industry's history.

98
article thumbnail

STAT+: FDA is petitioned to boost enforcement of trial sponsors that fail to register studies or report results

STAT

An organization that promotes and studies clinical trial disclosure has petitioned the Food and Drug Administration to take several steps to boost its enforcement of wayward trial sponsors and investigators that fail to register studies and report results. In arguing its case, the Universities Allied for Essential Medicines maintained the FDA has done such a poor job of enforcing the law that a lack of compliance “remains widespread” and potentially life-saving data have been kept

FDA 98
article thumbnail

PioneerRx Welcomes Medical Billing Platform TransactRx to the RedSail Family

PioneerRx

Irving, TX – PioneerRx is excited to welcome TransactRx into its family of innovative technology solutions. RedSail Technologies, PioneerRx’s parent company.

98
article thumbnail

STAT+: Hospital systems’ investment income perked up at end of 2022

STAT

Large hospital systems’ investments rebounded heavily in the final quarter of 2022, according to a new STAT analysis of financial filings. It wasn’t enough to erase the steep investment losses from the rest of the year, but the income provides extra cushion to hospitals that are still losing money from the daily operations of treating patients.

article thumbnail

The Age of Overprescribing | What You Can Do to Help

PioneerRx

Of all the medications that pharmacists dispense, antibiotics are one of the most important 一 but often, one of the most dangerous. Every year, over 150 million.

98
article thumbnail

2023: A Promising Year for ISPE’s Women in Pharma®

ISPE

2023: A Promising Year for ISPE’s Women in Pharma® Trudy Patterson Mon, 02/27/2023 - 11:49 iSpeak Blog iSpeak 2023: A Promising Year for ISPE’s Women in Pharma® Edyna Miguez 27 February 2023 Just off the heels of ISPE’s Facilities of the Future Conference, which took place this past February, ISPE’s Women in Pharma continues to leverage its momentum to amplify the group’s mission to create a more equitable pharmaceutical industry on a grand scale.

98
article thumbnail

Expanding the Role of Pharmacists

PioneerRx

For years, community pharmacists have offered patients the most accessible and affordable forms of care. Whether it be to fill a prescription, administer annual.

98
article thumbnail

CHMP recommends first pegylated enzyme for Fabry disease

European Pharmaceutical Review

PRX–102 (pegunigalsidase alfa), the first and only pegylated enzyme for adults with Fabry disease has been recommended by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). The novel recombinant human α–Galactosidase–A (α–Gal–A) enzyme is being investigated as a PEGylated enzyme replacement therapy (ERT) for Fabry disease.

98
article thumbnail

The Cure for Asthma + Other Oddities | Pharmacy History

PioneerRx

From the dark ages to the modern day, pharmacy has an impressive history. In this new series, we dive into some of the most notable moments in the pharmacy world.

98
article thumbnail

Digital natives: are pharma companies ready?

pharmaphorum

Engaging digitally native healthcare professionals requires companies to challenge existing business ethos and commit to the customer experience in an increasingly digital world.

98
article thumbnail

The Power of Personality Tests

PioneerRx

The Greek philosopher Socrates famously said, “Know thyself.” Personal knowledge and understanding, he believed, are the foundations for a happy, fulfilled life.

98
article thumbnail

STAT+: For Cytokinetics, an FDA rejection of its heart drug would help, not hinder

STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it. Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the b

FDA 98